<i>SERPINB9</i> is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade responseSofía Ibáñez-Molero, Daniel S. Peeper, Thomas Kuilman et al.|OncoImmunology|2022Cited by 33
An adverse tumor-protective effect of IDO1 inhibitionJuliana C.N. Kenski, Daniel S. Peeper, Ton N. Schumacher et al.|Cell Reports Medicine|2023Cited by 32